Bicycle Therapeutics Plc (BCYC)
3.86
+0.03
(+0.78%)
USD |
NASDAQ |
Sep 11, 16:00
3.88
+0.02
(+0.52%)
After-Hours: 20:00
Bicycle Therapeutics Price to Book Value : 0.5281 for Sept. 11, 2026
Price to Book Value Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Price to Book Value Data
| Date | Value |
|---|---|
| September 11, 2026 | 0.5281 |
| September 10, 2026 | 0.524 |
| September 09, 2026 | 0.548 |
| September 08, 2026 | 0.5719 |
| September 04, 2026 | 0.5883 |
| September 03, 2026 | 0.5801 |
| September 02, 2026 | 0.5883 |
| September 01, 2026 | 0.561 |
| August 31, 2026 | 0.5651 |
| August 28, 2026 | 0.5747 |
| August 27, 2026 | 0.5924 |
| August 26, 2026 | 0.5959 |
| August 25, 2026 | 0.6006 |
| August 24, 2026 | 0.5924 |
| August 21, 2026 | 0.5979 |
| August 20, 2026 | 0.5801 |
| August 19, 2026 | 0.5664 |
| August 18, 2026 | 0.5459 |
| August 17, 2026 | 0.5473 |
| August 14, 2026 | 0.5336 |
| August 13, 2026 | 0.5446 |
| August 12, 2026 | 0.5555 |
| August 11, 2026 | 0.5637 |
| August 10, 2026 | 0.5623 |
| August 07, 2026 | 0.5705 |
| Date | Value |
|---|---|
| August 06, 2026 | 0.5432 |
| August 05, 2026 | 0.5432 |
| August 04, 2026 | 0.5391 |
| August 03, 2026 | 0.5295 |
| July 31, 2026 | 0.5281 |
| July 30, 2026 | 0.5487 |
| July 29, 2026 | 0.5281 |
| July 28, 2026 | 0.5391 |
| July 27, 2026 | 0.5404 |
| July 24, 2026 | 0.5295 |
| July 23, 2026 | 0.5692 |
| July 22, 2026 | 0.576 |
| July 21, 2026 | 0.5692 |
| July 20, 2026 | 0.5692 |
| July 17, 2026 | 0.576 |
| July 16, 2026 | 0.5719 |
| July 15, 2026 | 0.5774 |
| July 14, 2026 | 0.576 |
| July 13, 2026 | 0.5952 |
| July 10, 2026 | 0.6034 |
| July 09, 2026 | 0.5719 |
| July 08, 2026 | 0.5856 |
| July 07, 2026 | 0.5993 |
| July 06, 2026 | 0.5952 |
| July 02, 2026 | 0.5952 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price to Book Value Benchmarks
| Autolus Therapeutics Plc | 8.920 |
| Akari Therapeutics Plc | 1.064 |
| Biodexa Pharmaceuticals Plc | -- |
| Cellectis SA | 7.601 |
| DBV Technologies SA | 3.373 |
Price to Book Value Related Metrics
| PS Ratio | 4.396 |
| Price | 3.86 |
| Earnings Yield | -70.76% |
| Market Cap | 194.45M |